Patents
Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
07/2011
07/27/2011EP1841780B1 Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
07/21/2011US20110178317 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
07/20/2011EP2344515A1 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
07/20/2011CN102131821A Glucocorticoids attached to nitrate esters via aromatic linker in position 21 and their use in ophthalmology
07/20/2011CN101360757B High purity 17alfa-cyanomethyl-17beta-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof
07/19/2011US7981876 Polymorphic and amorphous salt forms of squalamine dilactate
07/14/2011WO2010106383A8 Novel crystalline form of antiprogestin cdb-4124
07/07/2011US20110166334 Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
07/05/2011CA2448296C Methods of making 21-[4'-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
06/2011
06/22/2011EP2336146A1 17beta-hydroxysteroid dehydrogenase inhibitors
06/16/2011US20110144281 Amphiphilic polymers having a cholane core
06/15/2011CN101218246B Improved crystalline form of compound A-348441
06/02/2011US20110130581 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
06/02/2011US20110130376 New no releasing steroids derivatives
06/01/2011CN102083849A Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method
06/01/2011CN102079771A Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof
05/2011
05/31/2011CA2172282C Chiral surfactants and methods for their use in chiral separations
05/24/2011US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
05/24/2011US7947667 Aromatization; hydrolysis; deblocking, deprotecting; oxidation; for production of fulvestrant
05/19/2011WO2010136000A4 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
05/19/2011US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
05/18/2011EP2321334A1 New no releasing steroids derivatives
05/18/2011EP2320729A1 Glycoside compounds and pharmaceutical compositions thereof
05/18/2011CN102066397A Compounds including an anti-inflammatory pharmacore and methods of use
05/18/2011CN102066396A A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-B]pyridine
05/11/2011EP2318427A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
05/05/2011WO2011029639A3 Compounds and methods for treating neoplasia
05/03/2011CA2458626C Lipid derivatives of aminoglycosides
04/2011
04/28/2011WO2011009531A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
04/28/2011WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases
04/21/2011US20110092473 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
04/21/2011US20110092467 7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds
04/19/2011CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens
04/13/2011EP2307438A2 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method
04/13/2011EP2205620B1 Amorphous form of (11beta,16alpha)-9-fluoro-11-hydroxy-16,17-[(1-methylethyliden)bis(oxy)]-21-[[4- [(nitrooxy)methyl]benzoyl]oxy]-pregna-1,4-dien-3,20-dione
04/06/2011EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
04/06/2011CN102002085A Method for preparing epristeride
03/2011
03/31/2011WO2011036557A1 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
03/31/2011WO2011015892A3 Novel crystal form of cdb - 4124 and proces s for the preparation thereof
03/30/2011CN101993469A Method for preparing medicinal dienogest
03/30/2011CN101993468A Synthesis method for improving dienogest
03/29/2011CA2622798C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
03/24/2011WO2010136000A3 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
03/22/2011US7910571 3 beta -hydroxy-16 alpha -fluoro-17 beta -aminoandrost-5-ene; immunostimulant, antiinflammatory agent; neutropenia, infections, blood cell deficiencies; interleukin, tumor necrosis factor, macrophage inflammatory protein, transforming growth factor, cyclooxygenase, and lipoxygenase inhibitor
03/17/2011WO2011029639A2 Compounds and methods for treating neoplasia
03/10/2011WO2010139692A3 Antiviral triterpene derivatives
03/09/2011EP2292588A1 Ceramide dimers and their use as medicine or cosmetic preparation
03/03/2011US20110053902 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
02/2011
02/23/2011CN101981047A Novel lupane derivatives
02/22/2011US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase
02/22/2011CA2446314C Liver x receptor agonists
02/16/2011EP2283159A1 Synthesis of (+) cortistatin a and related compounds
02/16/2011CN101977924A Novel c-21-keto lupane derivatives preparation and use thereof
02/10/2011DE102009034526A1 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten 17-hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynyl-phenyl derivatives, to processes for their preparation and their use for the treatment of diseases
02/08/2011USRE42132 have special action with respect to tubulin polymerization inhibition and can be used for treating prostate cancer, breast cancer, colon cancer, non-small-cell-lung cancer, or primary dermal microvascular endothelial cell proliferation; 2-methoxy-17a-oxo-17a-homoestra-1,3,5(10)-trien-3-yl sulfamate
02/03/2011WO2010123545A3 Angiogenesis inhibitors
02/02/2011EP2279196A2 Compounds including an anti-inflammatory pharmacore and methods of use
02/02/2011EP2279195A1 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
01/2011
01/27/2011US20110021480 17-beta HSD1 and STS Inhibitors
01/27/2011DE102009034525A1 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten 17-hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl-derivatives, processes for their preparation and their use for the treatment of diseases
01/27/2011CA2768448A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases
01/27/2011CA2768407A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
01/11/2011US7867990 Steroid hormone products and methods for preparing them
01/06/2011US20110003782 23-Substituted Bile Acids as TGR5 Modulators and Methods of Use Thereof
01/06/2011US20110002983 Compound
01/04/2011CA2520142C Oestrogen derivatives as inhibitors of steroid sulphatase
12/2010
12/29/2010CN101463063B Method for synthesizing 3 alpha-hydroxy-2 beta-amidine-5 alpha-androst-17-keto compound
12/28/2010US7858608 orphan nuclear receptor modulators such as 23-N-Carbacinnamyloxy-3 alpha ,7 alpha -dihydroxy-5 beta -norcholanylamine, used for the treatment of liver, gastrointestinal, kidney, cardiovascular or metabolic disorders
12/28/2010US7858603 neuroprotectants such as 1,4-cholestadien-3-one oxime, used for the treatment of neurodegenerative diseases
12/28/2010US7858600 Non-antibiotic resistant; Gram-positive and Gram-negative bacteria; Salmonella, Streptococcus, Escherichia
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324004 Method for Treating Diabetes
12/23/2010US20100324003 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
12/23/2010US20100323976 Novel anti-inflammatory pro-drugs
12/22/2010CN101921202A Process for producing 1-sbustituted 3, 5-diaminobenzene
12/15/2010CN101918426A 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
12/08/2010EP2258713A1 Antiviral Triterpene Derivatives
12/02/2010WO2010136940A1 Novel glucocorticoid receptor agonists
12/02/2010DE102009041893A1 Verfahren zur Synthese von Diegonest ausgehend von Estron-3-methylether A process for the synthesis of Diegonest starting from estrone-3-methylether
12/02/2010CA2760284A1 Novel glucocorticoid receptor agonists
12/01/2010EP2256128A1 Method for synthesis of dienogest from estrone-3-methylether
11/2010
11/30/2010CA2217053C Method of photochemical immobilization of ligands using quinones
11/24/2010EP1599493B1 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
11/24/2010CN101896186A Means and methods for counteracting muscle disorders
11/24/2010CN101891791A Derivate for labeling bile acid and reference compound, preparation method and application thereof
11/18/2010US20100292201 Novel steroidal esters of 17-oximino-5-androsten-3beta-ol
11/18/2010US20100292184 17beta-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivative
11/18/2010US20100292176 Antitumor agent
11/17/2010EP2250185A1 Novel lupane derivatives
11/17/2010EP1910400B1 Improved crystalline form of the compound a-348441
11/16/2010CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses
11/11/2010WO2010128472A1 Method for the synthesis of glycocholic acid
11/11/2010US20100286107 Oligomer-Corticosteroid Conjugates
11/04/2010WO2010126953A1 Corticosteroid linked beta-agonist compounds for use in therapy
10/2010
10/28/2010WO2010123545A2 Angiogenesis inhibitors
10/28/2010US20100272979 Photoactive materials
10/21/2010WO2010071772A3 Synthesis of 3b-amino-5-cholestene and related 3b-halides involving i-steroid and retro-i-steroid rearrangements
10/20/2010CN101863947A Synthesis method of dienogest
10/19/2010US7816546 Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 47